gguy / Shutterstock.com

10 February 2026NewsPatentsLiz Hockley

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’

Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More articles

Top trial lawyer leaves Debevoise for premier corporate firm

Renault vows action over car sales ban following patent suit loss

Why open source patent protection is about ‘the global public good’

General Motors collides with aftermarket car industry

Nine-partner litigation team leaves Winston & Strawn

Shower power: How we washed away Mira’s claims against Triton

INTA exclusive: ‘Davos of IP’ will take London meeting to a ‘different level’

How we won: Promptu counsel on its $240m victory against Comcast

Copyright © worldipreview.com 2024 | Headless Content Management with Blaze